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a b s t r a c t
Pneumolysin (PLY) is a key virulence factor contributes to the pathogenesis of Streptococcus
pneumoniae. In this study we investigated the effect of allicin and aqueous garlic extracts on
hemolytic activity of PLY both in prelysed and intact cells. Additionally the antimicrobial
activity of allicinwas tested against the bacteria. All testedmaterials potently inhibited the PLY
hemolytic activity. Allicin neutralizes PLY in a concentration- and time-dependent manner.
Twenty five minute incubation of PLY (2 HU/mL) with 0.61 mM/mL concentration of allicin,
totally inhibited hemolytic activity of PLY (IC50 ¼ 0.28 mM/mL). The inhibitory activity of old
extract of garlic was similar to pure allicin (IC50 ¼ 50.46 mL/mL; 0.31 mM/mL; P < 0.05). In
contrast fresh extract of garlic inhibits the PLY hemolytic activity at lower concentrations
(IC50¼13.96mL/mL; 0.08mM/mLallicin). Exposure of intact cells to allicin (1.8mM) completely
inhibited hemolytic activity of PLY inside bacterial cells. The inhibitory effect of the allicinwas
restored by addition of reducing agent DTT at 5 mM, proposing that allicin likely inhibits the
PLY by binding to cysteinyl residue in the binding site. TheMIC value of allicinwas determined
to be 512 mg/mL (3.15 mM/mL). These results indicate that PLY is a novel target for allicin and
may provide a new line of investigation on pneumococcal diseases in the future.
! 2010 Elsevier Ltd. All rights reserved.
1. Introduction
Streptococcus pneumoniae causes several important
human diseases, including serious invasive diseases like as
pneumonia, septicemia and meningitis, in addition to otitis
media and acute sinusitis (Musher, 1992). This organism
produces several potential virulence factors responsible for
this broad range of diseases (Mitchell, 2000). Pneumolysin
(PLY) is a key multifunctional virulence factor contributes
to the pathogenesis of pneumococcal diseases and
produces by virtually all clinical isolates of S. pneumoniae
(Cockeran et al., 2002, 2003; Feldman and Anderson, 2009).
Several lines of evidence through both in vitro and in
vivo studies have revealed the potential role of PLY in the
pathogenesis of pneumococcal infections.
Invitro studies demonstrated that PLY is toxic tomainlyall
human cell types including pulmonary alveolar epithelial
cells (Rubins et al., 1993) and brain ciliated ependymal cells
(Mohammed et al., 1999) as well as neuronal cells (Braun
et al., 2007; Cockeran et al., 2002). It is capable of inhibiting
polymorphonuclear cell respiratory burst and chemotaxis,
inhibiting antibody production by human lymphocytes
in sublytic concentrations. Furthermore, pneumolysin con-
tributes to pathogenesis of pneumococcal diseases by its
pro-inflammatory activities; it promotes the production
and release of inflammatory factors like as IL-8, IL-6, IL-1b
and TNFa (Feldman and Anderson, 2007). Pneumolysin
also activates the complement system directly (Paton et al.,
1984). Similarly, a direct link between severity of invasive
pneumococcal diseases and pneumolysin has been shown
in experimental models. It has been demonstrated that
PLY-deficient S. pneumoniae injected inmicewas lessvirulent
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